176 related articles for article (PubMed ID: 17195061)
1. [Nuclear medical diagnostics for liver tumors].
Buck AK; Stollfuss JC; Stahl A; Beer AJ; Meisetschläger G; Schwaiger M
Internist (Berl); 2007 Jan; 48(1):21-4, 26-9. PubMed ID: 17195061
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic and hepatobiliary cancers.
Buck AK; Herrmann K; Eckel F; Beer AJ
Methods Mol Biol; 2011; 727():243-64. PubMed ID: 21331938
[TBL] [Abstract][Full Text] [Related]
3. The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors.
Frilling A; Sotiropoulos GC; Radtke A; Malago M; Bockisch A; Kuehl H; Li J; Broelsch CE
Ann Surg; 2010 Nov; 252(5):850-6. PubMed ID: 21037441
[TBL] [Abstract][Full Text] [Related]
4. Controversies in the management of colorectal liver metastases: role of PET and PET/CT.
Wiering B; Vogel WV; Ruers TJ; Oyen WJ
Dig Surg; 2008; 25(6):413-20. PubMed ID: 19212113
[TBL] [Abstract][Full Text] [Related]
5. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Buchmann I; Ganten TM; Haberkorn U
Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
De Gaetano AM; Rufini V; Castaldi P; Gatto AM; Filograna L; Giordano A; Bonomo L
Abdom Imaging; 2012 Dec; 37(6):983-1003. PubMed ID: 22527152
[TBL] [Abstract][Full Text] [Related]
7. [PET-CT for neuroendocrine tumors and nuclear medicine therapy options].
Scheidhauer K; Miederer M; Gaertner FC
Radiologe; 2009 Mar; 49(3):217-23. PubMed ID: 19296068
[TBL] [Abstract][Full Text] [Related]
8. 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography, computed tomography, and magnetic resonance imaging for the detection of experimental colorectal liver metastases.
de Jong GM; Hendriks T; Bleichrodt RP; Dekker HM; Mus RD; Gotthardt M; Visser EP; Oyen WJ; Boerman OC
Mol Imaging; 2012 Apr; 11(2):148-54. PubMed ID: 22469242
[TBL] [Abstract][Full Text] [Related]
9. Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma.
Trojan J; Schroeder O; Raedle J; Baum RP; Herrmann G; Jacobi V; Zeuzem S
Am J Gastroenterol; 1999 Nov; 94(11):3314-9. PubMed ID: 10566736
[TBL] [Abstract][Full Text] [Related]
10. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
[TBL] [Abstract][Full Text] [Related]
11. The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases.
Wiering B; Krabbe PF; Jager GJ; Oyen WJ; Ruers TJ
Cancer; 2005 Dec; 104(12):2658-70. PubMed ID: 16315241
[TBL] [Abstract][Full Text] [Related]
12. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
Chua S; Gnanasegaran G; Cook GJ
Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
[TBL] [Abstract][Full Text] [Related]
13. [Modern CT and PET/CT imaging of the liver].
Klasen J; Heusner TA; Riegger C; Reichelt D; Kuhlemann J; Antoch G; Blondin D
Radiologe; 2011 Aug; 51(8):671-9. PubMed ID: 21769701
[TBL] [Abstract][Full Text] [Related]
14. [Modern imaging for liver metastases from colorectal tumors].
Gaa J; Wieder H; Schwaiger M; Rummeny EJ
Chirurg; 2005 Jun; 76(6):525-6, 528-34. PubMed ID: 15875145
[TBL] [Abstract][Full Text] [Related]
15. [Nuclear medicine for evaluation of liver functions].
Yamamoto K
Kaku Igaku; 1994 May; 31(5):521-6. PubMed ID: 8028225
[TBL] [Abstract][Full Text] [Related]
16. Imaging modalities for the staging of patients with colorectal cancer.
Bipat S; Niekel MC; Comans EF; Nio CY; Bemelman WA; Verhoef C; Stoker J
Neth J Med; 2012 Jan; 70(1):26-34. PubMed ID: 22271811
[TBL] [Abstract][Full Text] [Related]
17. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment.
Niekel MC; Bipat S; Stoker J
Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538
[TBL] [Abstract][Full Text] [Related]
19. [Coexistence of hepatocellular carcinoma and hepatic metastasis: advantages of positron emission tomography for liver tumors].
Boursier J; Aubé C; Pilette C; Lassale V; Kerkeni N; Varache N
J Radiol; 2006 Nov; 87(11 Pt 1):1708-10. PubMed ID: 17095968
[TBL] [Abstract][Full Text] [Related]
20. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
